CELEX: 32018M8887
Language: en
Date: 2018-06-04 00:00:00
Title: Commission Decision of 04/06/2018 declaring a concentration to be compatible with the common market (Case No COMP/M.8887 - PLATINUM EQUITY / LIFESCAN) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                Brussels,4.6.2018
                                                                C(2018) 3674 final
                                                                       PUBLIC VERSION
                                                                To the notifying party:
Subject:        Case M.8887 – PLATINUM EQUITY / LIFESCAN
                Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC)
                                1                                                                             2
                No 139/2004 and Article 57 of the Agreement on the European Economic Area
Dear Sir or Madam,
1.      On 4 May 2018, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which Platinum Equity
        ("Platinum", USA), acquire within the meaning of Article 3(1)b of the Merger Regulation
        sole control of Lifescan Inc., part of Johnson&Johnson (USA) by way of purchase of
        shares and assets through a special purpose vehicle.3
2.      The business activities of the undertakings concerned are:
        −     for Platinum: a private investment firm, specialised in the merger, acquisition and
              operation of companies in a broad range of businesses, including information
              technology, telecommunications, logistics, metal services, manufacturing and
              distribution at global level.
        −     for LifeScan: provides blood glucose monitoring systems for home and hospital use
              under the global brand OneTouch. The OneTouch portfolio includes personal blood
              glucose meters, testing strips, lancets, point of care testing systems and integrated
              digital solutions.
1       OJ L 24, 29.1.2004, p. 1 (the 'Merger Regulation'). With effect from 1 December 2009, the Treaty on the
        Functioning of the European Union ('TFEU') has introduced certain changes, such as the replacement of
        'Community' by 'Union' and 'common market' by 'internal market'. The terminology of the TFEU will be used
        throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the 'EEA Agreement').
3       Publication in the Official Journal of the European Union No C 170, 17.05.2018, p. 12.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak--- 3. After examination of the notification, the European Commission has concluded that the
   notified operation falls within the scope of the Merger Regulation and of paragraph 5(b) of
   the Commission Notice on a simplified procedure for treatment of certain concentrations
   under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European Commission
   has decided not to oppose the notified operation and to declare it compatible with the
   internal market and with the EEA Agreement. This decision is adopted in application of
   Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement.
                                                    For the Commission
                                                    (Signed)
                                                    Johannes LAITENBERGER
                                                    Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                                  2